FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for Nexterone (amiodarone hydrochloride) submitted by Baxter Healthcare Company associated with NDA 022325.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiac Arrhythmia
• Ventricular Tachycardia

Drugs mentioned

• NEXTERONE (AMIODARONE HYDROCHLORIDE)

Snippet

SUPPL AP for NEXTERONE (AMIODARONE HYDROCHLORIDE)